Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
Sentinel Agents™, NexusPulse™ Intelligent Calculators, DrArturo AI™, Phoebe AI™, Patient Connect™, and TrialRelay™ create a real-time multi-agent orchestration layer for precision oncology access
Massive Bio today announced the next-generation product suite within Reticulum Nexus™, introducing a coordinated set of AI agents, intelligent calculators, signal engines, patient navigation tools, and physician referral workflows designed to move oncology access from fragmented trial matching to closed-loop orchestration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260530932788/en/ Massive Bio announces the next-generation Reticulum Nexus™ product suite at ASCO 2026. The future of oncology access is here.
The new suite brings together Patient Connect™, TrialRelay™, NexusPulse™, Sentinel Agents™, DrArturo AI™, and Phoebe AI™ into a real-time multi-agent ecosystem for patients, physicians, sites, sponsors, advocacy organizations, and health systems.
